Navigation Links
A Milestone of Opportunity for VNUS Medical Technologies
Date:6/8/2009

Over Half a Million Varicose Vein Patients Treated with VNUS Closure Procedure Worldwide

SAN JOSE, Calif., June 8 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS), a worldwide leader in medical devices for the minimally invasive treatment of venous reflux disease, the underlying cause of varicose veins, announced today that as of this week, it estimates the number of patients treated with the VNUS Closure radiofrequency vein ablation system has surpassed 500,000 worldwide. Thousands of physicians across the Americas, Europe and Asia have embraced the VNUS ClosureFAST(TM) catheter and ClosureRFS(TM) device as a highly effective minimally invasive medical technology for treating diseased leg veins and restoring healthy circulation to varicose vein patients.

VNUS solutions have also achieved widespread acceptance among medical insurers, with all major US health insurance insurers covering radiofrequency vein ablation for patients with symptomatic varicose veins and venous reflux. In addition, the VNUS procedure is available in 40 countries and is covered by the national health insurance systems in the UK and France.

"Achieving the physician, patient and insurer acceptance that has led to 500,000 patients treated with our VNUS Closure procedure is a tremendous milestone both for our company and for the field of minimally invasive vein treatment," said Brian E. Farley, VNUS' first employee in 1995 and President and CEO. "Although this accomplishment is notable, we expect that in the future our Closure products will ultimately help millions of patients suffering from venous reflux. We also believe that our success emanates from a strong commitment to product quality supported by clinical and comparative effectiveness trials of our products. The results of these trials have proven to the medical and payor community that the VNUS Closure catheter offers superior clinical benefits to patients compared to alternative therapies. We believe our physician customers and employees gain a deep sense of satisfaction from providing such high quality medical care and products to our most important constituents - the patients treated with VNUS Closure products."

VNUS' products have been featured in over 100 clinical publications and more than ten published book chapters. Some of the company's most significant milestones include:

  • 1995: Company founded, development of catheters using RF energy to controllably shrink veins
  • January 1998: First Closure procedure performed
  • March 1999: FDA clearance of the VNUS Closure catheter and radiofrequency generator
  • August 2003: Publication of randomized trial of the Closure catheter vs. vein stripping
  • September 2005: Publication of Closure clinical study confirming the long-term efficacy of the procedure
  • October 2005: FDA clearance of the Closure RFS device for treatment of perforator veins
  • August 2006: FDA clearance of ClosureFAST, the next-generation catheter
  • March 2007: Launch of the ClosureFAST catheter to physicians and the public
  • June 2008: VNUS licenses its patents for vein ablation to laser competitors
  • April 2009: UK National Health Service cites VNUS Closure procedure as a select innovative technology
  • May 2009: Covidien Ltd. announces intent to acquire VNUS
  • June 2009: Publication of randomized trial of the ClosureFAST catheter vs. laser ablation
  • June 2009: 500,000th Closure procedure performed.

ABOUT VNUS MEDICAL TECHNOLOGIES, INC.

Founded in 1995 and headquartered in San Jose, California, VNUS Medical Technologies (NASDAQ: VNUS) is a worldwide leader in medical devices for the minimally invasive treatment of venous reflux disease, a progressive condition that is the underlying cause of varicose veins. VNUS sells the Closure system, which consists of a proprietary radiofrequency (RF) generator and proprietary disposable endovenous catheters and devices to treat diseased veins through the application of temperature-controlled RF energy. For more information, please visit www.vnus.com.


'/>"/>
SOURCE VNUS Medical Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
2. Milestone Scientific Commences Declaratory Judgment Action With Respect to Its Single Tooth Anesthesia (STA(TM)) System and Compudent(TM) System
3. Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
4. Milestone Scientific to Exhibit the STA(TM) System at the American Dental Associations 148th Annual Session in San Francisco
5. Smurfit-Stones Hodge, LA, Mill Becomes First to Achieve Safety Milestone
6. Grand Opening of Regence Boys & Girls Club Marks a Milestone in Historic New Columbia Community Revitalization
7. Milestone Scientific to Present at the Edgewater Research Investor Conference
8. Isis Receives $1.25 Million Milestone Payment From iCo for Initiation of Phase 1 Study of iCo-007
9. Global Gene Map Clears New Milestone
10. Free Site Offering Patient-Physician Dialog Reaches Milestone
11. Marlo Thomas and St. Jude Childrens Research Hospital(R) Announce Hitting The 50-Partner Milestone as They Kick Off the Fourth Annual Thanks and Giving(R) Campaign Which Asks America to Support St. Jude While Shopping This Holiday Season
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... 2016 , ... Mediaplanet is proud to announce the launch ... innovative treatments, therapeutic technologies, and revolutionized nutrition that are helping patients and physicians ... years in the last 3 decades,” says Dr. Valentine Fuster, a world-renowned cardiologist. ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... diagnostic imaging systems and the first company to offer robotic imaging to ... at their tradeshow booth # 941 for the American Association of Equine Practitioners ...
(Date:12/2/2016)... ... 2016 , ... Yisrayl Hawkins, at The House of Yahweh in Abilene, Texas, ... Bible Prophecy. Yisrayl says this generation, known as the Last Generation, started in 1934 ... details line up exactly with Bible Prophecy – a protected way for those who ...
(Date:12/2/2016)... ... 02, 2016 , ... On November 24th, 2016, Thanksgiving morning, ... different sites throughout Miami-Dade and Broward counties. This is the largest meal delivery ... Thanksgiving morning by putting together individual meals via assembly lines and passing them ...
(Date:12/2/2016)... ... December 02, 2016 , ... ‘Tis the season for giving! Today, 20 ... the National Family Partnership and the Drug Enforcement Administration as part of the National ... the 10 winning schools who decorated their campuses with this year’s Red Ribbon Week ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , December 2, 2016 ... "In Vitro Diagnostics/IVD Market by Product (Instruments, Reagents, ... Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) - ... market is valued at USD 60.22 Billion in ... a CAGR of 5.5% during the forecast period ...
(Date:12/2/2016)... 2, 2016 On Thursday, December ... excellence in research, development and innovation in the biopharmaceutical ... was held in the presence of Sergey Tsyb, Vice ... Russian Federation , Natalia Sanina, First Vice Chairman ... , Head of Roszdravnadzor, National Service of Control in ...
(Date:12/2/2016)... 2, 2016 bioLytical Laboratories, ein Weltführer bei schnellen ... Mitgliedern des Apothekenbundes von Kenia eingeführt. Continue ... ... HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) bioLytical wurde ...
Breaking Medicine Technology: